Contact lens sensor provides 24-hour IOP monitoring

Article

A contact lens sensor is able to provide continuous 24-hour IOP monitoring for the management of glaucoma.

A contact lens sensor is able to provide continuous 24-hour IOP monitoring for the management of glaucoma.

Dr Kaweh Mansouri et al., Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, USA, studied 44 patients with suspected glaucoma or with established glaucoma.,/p>

Patients underwent two 24-hour IOP monitoring sessions, called S1 and S2, at a one-week interval. Pearson correlations were used to assess reproducibility of signal patterns and incidence of adverse events and tolerability were recorded.

The main adverse events were blurred vision in 82% of patients, conjunctival hyperemia in 80% and superficial punctate keratitis in 15%. Mean visual analog score was 27.2 mm in S1 and 23.8 mm S2. The overall correlation between the 2 sessions was 0.59.

The repeated use of the contact lens sensor proved to have good tolerability and safety. The reproducibility was fair to good, meaning that the contact lens sensor can be used for the management process of glaucoma.

The abstract can be found in the Archives of Ophthalmology.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.